The global Protein Sequencing Market is gaining steady momentum as pharmaceutical, biotechnology, and research organizations increasingly rely on advanced technologies to understand protein structures and amino acid sequences. Protein sequencing plays an important role in biologics development, drug discovery, biomarker research, quality control, and proteomics. According to the latest Market Research Future analysis, the market was valued at approximately USD 1.79 billion in 2025 and is projected to reach USD 2.98 billion by 2035, expanding at a CAGR of 4.72% from 2026 to 2035.
The growing development of biologics and biosimilars is one of the strongest factors supporting market expansion. Pharmaceutical companies increasingly require accurate protein characterization for drug development and regulatory submissions. At the same time, mass spectrometry continues to serve as a major technology for high-throughput protein analysis, while single-molecule sequencing and AI-enabled protein identification are creating new opportunities for the industry. North America currently represents the largest regional market, while Asia-Pacific is expected to experience the fastest growth through 2035.
Get Free Sample PDF Brochure:
Protein Sequencing Market – Request Free Sample
Market Drivers
Expansion of Biologics and Biosimilars
The continued growth of biologic drug pipelines is creating strong demand for reliable protein characterization. Protein sequence analysis is essential for confirming the identity and quality of biologic molecules, while biosimilar development requires detailed comparisons with reference products. As pharmaceutical companies expand their biologics portfolios, demand for sequencing instruments, reagents, consumables, and analytical services is expected to increase.
Adoption of Single-Molecule Protein Sequencing
Traditional protein analysis methods are increasingly being complemented by newer single-molecule technologies. These platforms can provide detailed protein identification and sequence information with reduced sample-processing requirements. Their potential for real-time analysis is encouraging pharmaceutical and research laboratories to evaluate next-generation sequencing solutions.
Growth of CRO-Based Research
Contract research organizations are becoming increasingly important within the protein sequencing ecosystem. Pharmaceutical companies, particularly smaller and mid-sized organizations, are outsourcing specialized protein analysis activities to CROs rather than maintaining expensive in-house infrastructure. This trend supports demand for sequencing services and recurring consumable purchases.
Increasing Use of Artificial Intelligence
AI and machine-learning technologies are improving the interpretation of complex proteomics datasets. AI-supported de novo peptide sequencing can help researchers analyze mass spectrometry data more efficiently and reduce dependence on conventional database-search approaches. The integration of intelligent software with sequencing instruments is expected to strengthen the software and services segment.
Rising Demand for Multi-Omics Research
Researchers are increasingly combining proteomic information with genomic and metabolomic datasets to obtain a more comprehensive understanding of biological systems. This growing emphasis on multi-omics research is creating additional applications for protein sequence analysis across drug discovery, precision medicine, and biomarker development.
Market Challenges
High Instrument Investment
Advanced protein sequencing and mass spectrometry systems require significant capital expenditure. The cost of instruments, laboratory infrastructure, maintenance, and specialized software can limit adoption among smaller laboratories and research organizations, particularly in emerging economies.
Shortage of Skilled Professionals
Operating advanced sequencing platforms requires specialized knowledge in proteomics, mass spectrometry, bioinformatics, and data interpretation. A shortage of trained professionals can increase implementation times and make it difficult for smaller laboratories to fully utilize sophisticated sequencing technologies.
Data Standardization Issues
Protein sequencing generates complex datasets that may differ across instrument manufacturers and software ecosystems. Interoperability and data-standardization challenges can increase validation requirements and complicate the integration of information generated by different platforms.
Complex Sample Preparation
Sample preparation remains an important consideration in protein sequencing workflows. Researchers may need to perform several preparation and enrichment steps before obtaining suitable samples for analysis. These requirements can affect workflow efficiency, particularly when laboratories process large numbers of samples.
Browse In-depth Market Research Report on Protein Sequencing:
Protein Sequencing Market Research Report
Market Segmentation
By Products & Services
The Protein Sequencing Market is segmented into instruments, reagents and consumables, and software and services. Software and services accounted for around 41% of market revenue in 2025, reflecting the increasing use of cloud-based analytical platforms. Reagents and consumables are projected to expand at a 6.9% CAGR through 2035 because sequencing workflows require recurring purchases. Instruments generated approximately USD 0.62 billion in revenue in 2025.
By Technology
The market includes mass spectrometry, Edman degradation, protein chip technology, and nucleic acid sequencing. Mass spectrometry remains an important technology for high-throughput protein analysis, while next-generation and single-molecule approaches are gaining attention because of their potential to improve protein identification and sequencing workflows.
By Application
Applications include biomedical research, drug discovery, diagnostics, proteomics, biotherapeutics quality control and discovery, biomarker discovery, protein engineering, and synthetic biology. Biotherapeutics quality control and discovery represented approximately 39% of market share in 2025. Synthetic biology and cell-free systems are expected to record the fastest growth, with a projected 13.1% CAGR through 2035.
By End User
The major end users include pharmaceutical companies, biotechnology companies, academic and government institutions, and contract research organizations. Pharmaceutical companies held approximately 57% of the market in 2025 because of their extensive biologics research and quality-control activities. CROs are expected to be the fastest-growing end-user segment, supported by increasing outsourcing of specialized sequencing work.
Regional Insights
North America
North America leads the global Protein Sequencing Market, accounting for approximately 46% of market share in 2025. Strong pharmaceutical and biotechnology research activity, established proteomics infrastructure, and substantial research funding support regional demand. The United States represents the majority of the North American market.
Europe
Europe holds approximately 26% of the market and benefits from its established pharmaceutical industry, academic research infrastructure, and increasing demand for protein characterization associated with biologic and biosimilar development. Germany represents a major market within the region, supported by its strong proteomics research base.
Asia-Pacific
Asia-Pacific is projected to be the fastest-growing regional market, with an estimated CAGR of 9.4% between 2026 and 2035. Increasing biotechnology investments, expanding pharmaceutical manufacturing, CRO development, and government-backed research initiatives in China and India are supporting market growth. India is emerging as an important outsourcing hub for proteomics and protein analysis services.
South America
South America represents a developing market for protein sequencing. Brazil accounts for a significant portion of regional demand, supported by academic research programs and investment in proteomics infrastructure. Increasing laboratory modernization is expected to gradually improve adoption across the region.
Middle East & Africa
The Middle East and Africa market is still developing but offers opportunities through expanding biotechnology infrastructure and government-backed life-science initiatives. Saudi Arabia and the UAE are investing in research and biotechnology capabilities, while South Africa remains an important academic and research market.
Key Players
Key companies profiled in the Protein Sequencing Market include:
- Thermo Fisher Scientific
- Bruker Corporation
- Agilent Technologies
- Waters Corporation
- Shimadzu Corporation
- Danaher Corporation / Sciex
- Quantum-Si
- Bio-Rad Laboratories
- Promega Corporation
- PerkinElmer / Revvity
These companies are competing through advanced mass spectrometry platforms, sequencing technologies, analytical software, reagents, consumables, automation, and next-generation protein identification solutions.
Future Outlook
The future of the Protein Sequencing Market is expected to be shaped by the convergence of sequencing technologies, artificial intelligence, proteomics, and multi-omics analysis. AI-assisted interpretation could become increasingly integrated into commercial protein sequencing workflows, improving the speed and accuracy of peptide identification.
Another important trend will be the growing platform-based business model in which instruments are combined with proprietary reagents, consumables, and analytical software. Subscription-based reagent and service models may help laboratories reduce upfront investment while providing vendors with recurring revenue.
Clinical proteomics also represents a promising long-term opportunity. As protein biomarkers become increasingly relevant to diagnostics and precision medicine, sequencing technologies could find wider use in clinical research and companion-diagnostic development. At the same time, greener laboratory workflows and reduced chemical waste may influence purchasing decisions as sustainability becomes more important in life-science research.
Overall, the Protein Sequencing Market is positioned for sustained expansion through 2035, supported by biologics development, outsourcing, AI-enabled analysis, next-generation sequencing platforms, and increasing investment in proteomics research.
Related Report:
Uncover future growth patterns with expert-driven reports:
Clinical Chemistry Enzyme Market Outlook
Cell Therapy Growth Factor Market Analysis
Intermittent Pneumatic Compression IPC Device Market Distribution
Intravascular Optical Coherence Tomography Imaging System Market Size
Dental Soft Tissue Regeneration Market Share
About Market Research Future:
Market Research Future (MRFR) is a global market research and business consulting organization providing research reports, industry analysis, forecasts, and strategic insights across multiple sectors. Its research coverage includes healthcare, life sciences, technology, chemicals, energy, aerospace, and other major industries.
Follow Us:
Stay connected with Market Research Future for market intelligence, industry trends, business insights, and emerging technology developments.
Contact:
Market Research Future
Email: sales@marketresearchfuture.com
